News

Procure4Health Call for Twinnings

Published on | 2 years ago

Programmes Health

Procure4Health is looking for public & private procurers to support Twinnings activities in Health & Social care in order to share knowledge, build capacities of procurers, define common needs and advance innovation procurement in Europe. The Call for Twinnings is now open (cascade funding). Deadline to apply is 31 May 2023.

Benefits for awarded applicants:
- Learn about and adopt innovation procurement practices from others
- Get up to €30.000 to cover a wide range of Twinnings' activities
- Find your Twinning partner by using the Matchmaking pool

More information is available on the dedicated webpage. You can rewatch the information webinar held on 12 April on the call here

Background: The Horizon 2020 funded project Procure4Health is a growing community of European Health organisations interested in procurement of innovation.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1602 articles available search in articles 

Testimonial

image of ERC grants for UGent professor Lieven Eeckhout

ERC grants for UGent professor Lieven Eeckhout

Professor Lieven Eeckhout’s main research interests include computer architecture and the hardware/software interface with a specific emphasis on performance evaluation and modeling, and dynamic resource management.

Professor Eeckhout is the recipient of a European Research Council (ERC) Starting grant, Advanced grant and three Proof of Concept grants. Two of his former PhD students founded in 2013 CoScale, a spin-off in data center monitoring, which was acquired by New Relic.